您的购物车当前为空
别名 GPR39-C3
TC-G-1008 (GPR39-C3) 是一种口服有活性的 GPR39激动剂,可作用于大鼠受体(EC50: 0.4 nM)和人类受体(EC50:0.8 nM)的。


为众多的药物研发团队赋能,
让新药发现更简单!
TC-G-1008 (GPR39-C3) 是一种口服有活性的 GPR39激动剂,可作用于大鼠受体(EC50: 0.4 nM)和人类受体(EC50:0.8 nM)的。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 376 | 现货 | |
| 5 mg | ¥ 892 | 现货 | |
| 10 mg | ¥ 1,530 | 现货 | |
| 25 mg | ¥ 3,230 | 现货 | |
| 50 mg | ¥ 4,530 | 现货 | |
| 100 mg | ¥ 6,350 | 现货 | |
| 200 mg | ¥ 8,560 | 现货 | |
| 1 mL x 10 mM (in DMSO) | ¥ 971 | 现货 |
TC-G-1008 相关产品
| 产品描述 | TC-G-1008 (GPR39-C3) is a GPR39 (zinc receptor) agonist (EC50 values are 0.4 and 0.8 nM for rat and human receptors respectively). |
| 靶点活性 | GPR139 (human):0.8 nM, GPR39 (rat):0.4 nM |
| 体外活性 | TC-G-1008在一系列激酶上显示出选择性(IC50s>10 μM),且对相关的ghrelin和neurotensin-1受体没有显著的结合亲和力(IC50s>30 μM)[1]。在HEK293-GPR39细胞中,GPR39-C3是一种正向异构调节因子,能激活cAMP产生(Gs下游)、IP1积累(Gq下游)、SRF-RE依赖的转录(G12/13下游)和β-arrestin招募。GPR39-C3通过第二次化合物挑战,以剂量和时间依赖的方式导致对cAMP产生的响应丧失[2]。 |
| 体内活性 | TC-G-1008对大鼠和小鼠的血浆蛋白结合率分别为99.3%和99.1%。TC-G-1008是首个强效的GPR39激动剂(人类和大鼠受体的EC50s ≤ 1 nM),能够通过口服在小鼠中生物可用,并显著诱导急性GLP-1水平。经过一次性口服0.5%甲基纤维素/0.1%Tween 80水悬剂中的10、30和100 mg/kg剂量,TC-G-1008在1至1.5小时内分别达到1.4、6.1和25.3 μM的最大暴露水平[1]。 |
| 激酶实验 | HEK293-GPR39 cells are plated and cultured in poly-d-lysine-coated, white, 384-well plates (4000 cells/well) in the growth medium overnight at 37°C in the presence of 5% CO2. For pretreatment of the cells with GPR39 ligands (TCG-1008) or vehicle control (DMSO), the culture medium is removed and the cells are stimulated with GPR39 ligands in assay buffer for the indicated time at 37°C. Then, the compound solution is removed and washed twice with PBS containing 0.1% BSA. For measurement of intracellular cAMP, the cells are stimulated with drugs in stimulation buffer for 30 min at 37°C. The intracellular cAMP level is determined by using HTRF cAMP dynamic 2 kit[2] . |
| 动物实验 | Mice: Mice are given single oral doses of 10, 30, and 100 mg/kg of TC-G-1008[1] . |
| 别名 | GPR39-C3 |
| 分子量 | 418.9 |
| 分子式 | C18H19ClN6O2S |
| CAS No. | 1621175-65-2 |
| Smiles | CNc1nc(NCc2ccc(NS(C)(=O)=O)cc2Cl)cc(n1)-c1ccccn1 |
| 密度 | 1.462 g/cm3 (Predicted) |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 255 mg/mL (608.74 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| 体内实验配方 | 10% DMSO+40% PEG300+5% Tween 80+45% Saline: 2 mg/mL (4.77 mM), Sonication is recommended. 请按顺序添加溶剂,在添加下一种溶剂之前,尽可能使溶液澄清。如有必要,可通过加热、超声、涡旋处理进行溶解。工作液建议现配现用。以上配方仅供参考,体内配方并不是绝对的,请根据不同情况进行调整。 | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容